173 related articles for article (PubMed ID: 8568289)
21. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
[TBL] [Abstract][Full Text] [Related]
22. Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes.
Pérez-Gracia T; Galán F; Fernández-Gutiérrez C; Girón JA; Rodríguez-Iglesias M
Liver; 1999 Aug; 19(4):288-93. PubMed ID: 10459626
[TBL] [Abstract][Full Text] [Related]
23. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy.
Kawano S; Tanaka M; Fujiyama S; Sato S; Taura Y; Goto M; Chikazawa H; Sato T
J Gastroenterol Hepatol; 1994; 9(3):217-22. PubMed ID: 7519894
[TBL] [Abstract][Full Text] [Related]
24. Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis.
Giostra F; Manzin A; Lenzi M; Francesconi R; Solforosi L; Manotti P; Muratori L; Zauli D; Clementi M; Bianchi FB
J Hepatol; 1996 Oct; 25(4):433-8. PubMed ID: 8912141
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
26. Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters.
Berg T; Hopf U; Stark K; Baumgarten R; Lobeck H; Schreier E
J Hepatol; 1997 Mar; 26(3):484-91. PubMed ID: 9075653
[TBL] [Abstract][Full Text] [Related]
27. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
[TBL] [Abstract][Full Text] [Related]
28. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
[TBL] [Abstract][Full Text] [Related]
29. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
30. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
[TBL] [Abstract][Full Text] [Related]
31. Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein.
Kaneko T; Nakamura I; Kita H; Hiroishi K; Moriyama T; Imawari M
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1305-9. PubMed ID: 8683220
[TBL] [Abstract][Full Text] [Related]
32. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of quantitative assay for antibody to hepatitis C virus core in patients treated with interferon.
Yoshimura E; Hayashi J; Kishihara Y; Yamaji K; Kinukawa N; Kashiwagi S
Dig Dis Sci; 1996 Jan; 41(1):155-60. PubMed ID: 8565749
[TBL] [Abstract][Full Text] [Related]
34. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY
J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994
[TBL] [Abstract][Full Text] [Related]
35. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b.
Carlos MP; Yamamura Y; Vu Q; Conzen K; Anderson DE; Torres JV
Clin Immunol; 2004 Apr; 111(1):22-7. PubMed ID: 15093548
[TBL] [Abstract][Full Text] [Related]
36. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
[TBL] [Abstract][Full Text] [Related]
37. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
38. Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections.
Chuang WC; Allain JP
J Gen Virol; 2008 Aug; 89(Pt 8):1890-1900. PubMed ID: 18632960
[TBL] [Abstract][Full Text] [Related]
39. Serological pattern of hepatitis C virus recurrence after liver transplantation.
Rehermann B; Seifert U; Tillmann HL; Michel G; Böker KH; Pichlmayr R; Manns MP
J Hepatol; 1996 Jan; 24(1):15-20. PubMed ID: 8834019
[TBL] [Abstract][Full Text] [Related]
40. Virus-induced autoimmunity in hepatitis C virus infections: a rare event.
McFarlane BM; Bridger C; Tibbs CJ; Saleh MG; Fuzio A; Verucchi G; Attard L; Boschi A; Chiodo F; McFarlane IG
J Med Virol; 1994 Jan; 42(1):66-72. PubMed ID: 7508490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
